Supplementary information

The supplementary information relates to non-IFRS information and does not form part of the audited financial statements.

1 ADJUSTED PROFIT (EBITDA) EARNINGS FOR MANAGEMENT EARNINGS (NON-IFRS INFORMATION)
 

EBITDA excludes the effects from significant items of income and expenditure which may have an impact on the quality of earnings such as depreciation, amortisation, net finance income and impairments. It also excludes the effects of equity-settled share-based payments.

  Healthcare 
SA 
R'000 		 Healthcare 
Africa 
R'000 		 Healthcare 
Retail 
R'000 		 Total 
Healthcare 
R'000 		 Information 
Technology 
R'000 		 Inter-Group 
eliminations 
R'000 		 Group 
R'000 		   
Year ended 30 June 2020                 
Profit before taxation  196 426  50 728  235 829  482 983  149 014  (18 440) 613 557    
Depreciation and amortisation  23 245  4 525  12 271  40 041  149 308  37 317  226 666    
Reversal of impairment  16 116  –  341  16 457  –  (13 538) 2 919    
Share-based payment expense  8 026  317  775  9 118  5  (2) 9 121    
Net finance income/(cost) 15 757  (1 612) 3 521  17 666  (982) 317  17 001    
Adjusted Profit for the year (EBITDA) 259 570  53 958  252 737  566 265  297 345  5 654  869 264    
   Healthcare 
SA 
R'000 		 Healthcare 
Africa 
R'000 		 Healthcare 
Retail 
R'000 		 Total 
Healthcare 
R'000 		 Information 
Technology 
R'000 		 Inter-Group 
eliminations 
R'000 		 Group 
R'000 		   
Year ended 30 June 2019                 
Profit before taxation  147 644  63 382  117 537  328 563  75 800  124 124  528 487    
Depreciation and amortisation  96 404  8 399  22 572  127 375  110 599  (71 124) 166 850    
Add back impairment of assets  35 748  –  –  35 748  47 000  (14 487) 68 261    
Share-based payment expense  5 996  562  281  6 839  947  (1) 7 785    
Net finance income/(cost) 1 156  (515) 5 143  5 784  22 653  (32 908) (4 471)   
Adjusted profit for the year (EBITDA) 286 948  71 828  145 533  504 309  256 999  5 604  766 912    
2 NORMALISED EARNINGS PER SHARE
 
  Group
   2020 
R'000 		    Restated 
2019 
R'000 		   
Normalised earnings (non-IFRS information)1         
Headline earnings  306 750     265 241    
Adjusted by:         
Less: Lease reversal  (86 129)    (94 418)   
Add: Depreciation on right of use assets  71 781     82 666    
Add: Interest on lease liability  27 886     31 822    
Total tax effect of adjustments  (3 791)    (5 620)   
Total NCI effects of adjustments  (2 797)    (4 147)   
Normalised headline earnings  313 700     275 544    
Normalised headline earnings per share (cents)        
Basic  54.63     49.13    
Diluted  53.52     48.39    
1 Given the material non- cash, non- trading and non- recurring deductions which have a significant adverse impact on the earnings, management has adopted a non-IFRS earnings measure model.